VMP 41947111000001102

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Co-amoxiclav 500mg/100mg powder for solution for injection vials
BNF code 0501013K0AAAEAE
Virtual Therapeutic Moiety Co-amoxiclav
Date identifier became valid 9 Jun 2023
Previous product identifier 323567000
Abbreviated name Co-amoxiclav 500mg/100mg inj vials
Basis of preferred name BAN - British Approved Name
Date of name applicability 18 May 2004
Previous name Co-amoxiclav 500mg/100mg injection vials
Basis of previous name BAN - British Approved Name
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units vial
Unit dose unit of measure vial
Virtual Product Ingredient
Ingredient Amoxicillin sodium
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 372687004
Strength value numerator 500.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Potassium clavulanate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 395939008
Strength value numerator 100.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route solutioninfusion.intravenous
Ontology Drug Form & Route
Form & Route solutioninjection.intravenous
Dose Form
Formulation Powder for solution for injection
Drug Route
Route Intravenous
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Co-amoxiclav 500mg/100mg powder for solution for injection vials (Bowmed Ibisqus Ltd)
Co-amoxiclav 500mg/100mg powder for solution for injection vials (Sandoz Ltd)
Co-amoxiclav 500mg/100mg powder for solution for injection vials (Wockhardt UK Ltd)
Virtual Medicinal Product Packs
Co-amoxiclav 500mg/100mg powder for solution for injection vials 10 vial

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback